Nuveen Asset Management, LLC

Holdings History for Revance Therapeutics, Inc. - COM (RVNC)

Symbol: RVNC on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024	0%	0%	$2.36M	455K	-600,749	-56.9%	$5.19	Q3 2024
6/30/2024	0%	+0%	$2.71M	1.06M	+704,020	+200%	$2.57	Q2 2024
3/31/2024	0%	0%	$1.73M	352K	-181,154	-34%	$4.92	Q1 2024
12/31/2023	0%	0%	$4.69M	533K	-70,301	-11.6%	$8.79	Q4 2023
9/30/2023	0%	+0%	$6.92M	603K	+201,103	+50%	$11.47	Q3 2023
6/30/2023	0%	+0%	$10.2M	402K	+112	+0.03%	$25.31	Q2 2023
3/31/2023	0%	0%	$13M	402K	-98,565	-19.7%	$32.21	Q1 2023
12/31/2022	0%	0%	$9.25M	501K	-118,317	-19.1%	$18.46	Q4 2022
9/30/2022	0.01%	+0%	$16.7M	619K	+260,044	+72.4%	$27.00	Q3 2022
6/30/2022	0%	0%	$4.96M	359K	-11,701	-3.16%	$13.82	Q2 2022
3/31/2022	0%	0%	$7.07M	371K	-2,911	-0.78%	$19.06	Q1 2022
12/31/2021	0%	0%	$6.1M	374K	-10,932	-2.84%	$16.32	Q4 2021
9/30/2021	0%	0%	$10.7M	385K	-176,430	-31.4%	$27.86	Q3 2021
6/30/2021	0%	+0%	$16.6M	561K	+104,771	+23%	$29.64	Q2 2021
3/31/2021	0%	0%	$12.8M	456K	-19,826	-4.16%	$27.95	Q1 2021
12/31/2020	0%	+0%	$13.5M	476K	+50,128	+11.8%	$28.34	Q4 2020
9/30/2020	0%	+0%	$10.7M	426K	+25,165	+6.28%	$25.14	Q3 2020
6/30/2020	0%	+0%	$9.79M	401K	+49,606	+14.1%	$24.42	Q2 2020
3/31/2020	0%	+0%	$5.2M	351K	+24,534	+7.51%	$14.80	Q1 2020
12/31/2019	0%	+0%	$5.3M	327K	+19,344	+6.29%	$16.23	Q4 2019
9/30/2019	0%	+0%	$4M	307K	+104,035	+51.2%	$13.00	Q3 2019
6/30/2019	0%	+0%	$2.64M	203K	+203,337	NEW	$12.97	Q2 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.